Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
11.96
+0.55 (4.82%)
At close: Jul 22, 2026, 4:00 PM EDT
11.96
0.00 (0.00%)
After-hours: Jul 22, 2026, 7:00 PM EDT
Core Laboratories Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Core Laboratories stock has a consensus rating of "Hold" and an average price target of $15.5. The average 1-year stock price forecast is 29.60% higher than the current stock price, while the lowest is $11 (-8.03%) and the highest is $22 (+83.95%).
Price Target: $15.5 (+29.60%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Core Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Sell Reiterates $12 → $11 | Sell | Reiterates | $12 → $11 | -8.03% | Jul 15, 2026 |
Financial Forecast
Revenue This Year
510.79M
from 526.52M
Decreased by -2.99%
Revenue Next Year
539.55M
from 510.79M
Increased by 5.63%
EPS This Year
0.43
from 0.75
Decreased by -42.67%
EPS Next Year
0.68
from 0.43
Increased by 56.98%
EPS and Forward PE are based on non-GAAP adjusted numbers.